Liver Function and Portal-Systemic Shunting Quantified by the Oral Cholate Challenge Test and Risk for Large Esophageal Varices
Aliment Pharmacol Ther 2024 May 22
|
Hepatic Dysfunction Quantified by HepQuant DuO Outperforms Child-Pugh Classification in Predicting the Pharmacokinetics of Ampreloxetine
Clin Pharmacol Ther 2024 Apr 23
|
Dynamic elevation of aromatic amino acids in Hepatitis C Virus induced cirrhosis after a standard meal
Clinical and Translational Gastroenterology 2024;15:e00666
|
Advances in Noninvasive Measurement of Liver Function and Physiology: The HepQuant DuO Test
Basic Clin Pharmacol Toxicol 2024 Jan 15. Mar;134(3):385-395
|
Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt
Aliment Pharmacol Ther, 26(3):401-10
|
Compartmental model describing the physiological basis for the HepQuant SHUNT test
Transl Res. Volume 252, P53-63, February 2023
|
HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease
Clin Gastroenterol Hepatol. 2021 Apr 22;S1542-3565(21)00464-X
|
Predicting clinical decompensation in patients with cirrhosis using the HepQuant SHUNT Test
Aliment Pharmacol Ther. 2021 Apr;53(8):928-938
|